The Medical and Surgical Practice of NaProTECHNOLOGY, 2004

Chapter 86: Summary of NaProTECHNOLOGY Biomarkers

Thomas W Hilgers , M.D.

Author affiliations
  • Pope Paul VI Institute for the Study of Human Reproduction, Omaha, Nebraska. ROR

Abstract

NaProTECHNOLOGY utilizes a defined panel of cycle-phase-specific biomarkers — including targeted progesterone, estradiol, LH, FSH, and prolactin drawn at CrMS-standardized cycle days — to characterize the hormonal profile underlying each patient's reproductive dysfunction. This biomarker summary consolidates reference ranges, collection timing rules, and clinical interpretation frameworks that govern diagnosis and treatment decisions across infertility, endometriosis, recurrent pregnancy loss, and cycle irregularity.

Topics

what biomarkers does NaProTechnology track, what does the mucus cycle score mean, luteinized unruptured follicle diagnosis serial ultrasound, limited mucus cycle and miscarriage risk, premenstrual spotting causes on fertility chart, can fertility charting predict bone density loss, CrMS chart versus ultrasound due date accuracy, ovulation disorder classification NaProTechnology

Related articles